Sartorius Stedim Biotech SA
DIM
Company Profile
Business description
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
Contact
Otto-Brenner-Strasse 20
Goettingen37079
DEUT: +49 5513080
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
9,961
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,244.80 | 11.80 | -0.13% |
| CAC 40 | 7,974.85 | 3.07 | 0.04% |
| DAX 40 | 24,385.78 | 7.49 | 0.03% |
| Dow JONES (US) | 46,602.98 | 91.99 | -0.20% |
| FTSE 100 | 9,483.58 | 4.44 | 0.05% |
| HKSE | 26,758.38 | 199.39 | -0.74% |
| NASDAQ | 22,788.36 | 153.30 | -0.67% |
| Nikkei 225 | 47,787.83 | 163.05 | -0.34% |
| NZX 50 Index | 13,568.48 | 37.19 | 0.27% |
| S&P 500 | 6,714.59 | 25.69 | -0.38% |
| S&P/ASX 200 | 8,947.60 | 10.80 | -0.12% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |